Immunological ignorance allows long-term gene expression after perinatal recombinant adeno-associated virus-mediated gene transfer to murine airways

Human Gene Therapy

Volumn 25, Issue 6, 2014, Pages 517-528

  Carlon, Marianne S ^a   Vidović, Dragana ^a   Dooley, James ^b,c   Da Cunha, Marina Mori ^a,b   Maris, Michael ^b   Lampi, Youlia ^b,c   Toelen, Jaan ^b   Van Den Haute, Chris ^b,d   Baekelandt, Veerle ^b   Deprest, Jan ^b   Verbeken, Erik ^b   Liston, Adrian ^b,c   Gijsbers, Rik ^a,d   Debyser, Zeger ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d KU LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FETUS; GENE EXPRESSION; IMMATURITY; IMMUNE RESPONSE; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOSYNTHESIS; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; PROCEDURES; RESPIRATORY SYSTEM; VIROLOGY; VIRUS CAPSID;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BETA-GALACTOSIDASE; CAPSID; DEPENDOVIRUS; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HEK293 CELLS; HUMANS; IMMUNE TOLERANCE; MICE; RESPIRATORY SYSTEM; TRANSDUCTION, GENETIC;

EID: 84902981635     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.196     Document Type: Article

References (53)

1. Auricchio, A., O'Connor, E., Weiner, D., et al. (2002). Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J. Clin. Invest. 110, 499-504. (Pubitemid 34919704)
2. Beck, S.E., Jones, L.A., Chesnut, K., et al. (1999). Repeated delivery of adeno-associated virus vectors to the rabbit airway. J. Virol. 73, 9446-9455. (Pubitemid 29487100)
3. Carlon, M., Toelen, J., Van Der Perren, A., et al. (2010). Efficient gene transfer into the mouse lung by fetal intratracheal injection of rAAV2/6.2. Mol. Ther. 18, 2130-2138.
4. Carlon, M.S., Toelen, J., Da Cunha, M.M., et al. (2012). A novel surgical approach for intratracheal administration of bioactive agents in a fetal mouse model. J. Vis. Exp. 68.
5. Crystal, R.G., McElvaney, N.G., Rosenfeld, M.A., et al. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42-51.
6. + regulatory/suppressor T cells in human fetuses. Blood 105, 4715-4721. (Pubitemid 40807294)
7. Deprest, J.A., Devlieger, R., Srisupundit, K., et al. (2009). Fetal surgery is a clinical reality. Semin. Fetal Neonatal Med. 15, 58-67.
8. Dismuke, D.J., Tenenbaum, L., and Samulski, R.J. (2013). Biosafety of recombinant adeno-associated virus vectors. Curr. Gene Ther. 13, 434-452.
9. Flageul, M., Aubert, D., Pichard, V., et al. (2009). Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2/8 vectors. J. Gene Med. 11, 689-696.
10. Flotte, T.R., Zeitlin, P.L., Reynolds, T.C., et al. (2003). Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study. Hum. Gene Ther. 14, 1079-1088.
11. Fontenot, J.D., Dooley, J.L., Farr, A.G., and Rudensky, A.Y. (2005). Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906. (Pubitemid 41396890)
12. Gao, G., Vandenberghe, L.H., Alvira, M.R., et al. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388. (Pubitemid 38715936)
13. Gao, G.P., Alvira, M.R., Wang, L., et al. (2002). Novel adenoassociated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859. (Pubitemid 34994488)
14. Goudy, K.S., Annoni, A., Naldini, L., and Roncarolo, M.G. (2011). Manipulating immune tolerance with micro-RNA regulated gene therapy. Front. Microbiol. 2, 221.
15. Grubb, B.R., and Boucher, R.C. (1999). Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol. Rev. 79, S193-S214. (Pubitemid 29058915)
16. Halbert, C.L., Standaert, T.A., Aitken, M.L., et al. (1997). Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J. Virol. 71, 5932-5941. (Pubitemid 27304930)
17. Halbert, C.L., Rutledge, E.A., Allen, J.M., et al. (2000). Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74, 1524- 1532. (Pubitemid 30044103)
18. Harvey, B.G., Leopold, P.L., Hackett, N.R., et al. (1999). Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin.Invest. 104, 1245-1255. (Pubitemid 29536295)
19. Hu, C., Cela, R.G., Suzuki, M., et al. (2011). Neonatal helperdependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII. Proc. Natl. Acad. Sci. U.S.A. 108, 2082-2087.
20. Kamikozuru, K., Fukunaga, K., Hirota, S., et al. (2009). The expression profile of functional regulatory T cells, CD4+ CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease. Clin. Exp. Immunol. 156, 320-327.
21. Li, H., Murphy, S.L., Giles-Davis, W., et al. (2007). Preexisting AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes. Mol. Ther. 15, 792-800.
22. Limberis, M., Bell, P., and Wilson, J.M. (2007). Detection of reporter gene expression in murine airways. Methods Mol. Biol. 411, 25-34. (Pubitemid 351367195)
23. Limberis, M.P., and Wilson, J.M. (2006). Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc. Natl. Acad. Sci. U.S.A. 103, 12993-12998. (Pubitemid 44338905)
24. Limberis, M.P., Vandenberghe, L.H., Zhang, L., et al. (2009). Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol. Ther. 17, 294-301.
25. Lipshutz, G.S., Flebbe-Rehwaldt, L., and Gaensler, K.M. (2000). Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol. Ther. 2, 374-380.
26. Liqun Wang, R., McLaughlin, T., Cossette, T., et al. (2009). Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of a-1-antitrypsin using invasive and noninvasive delivery. Mol. Ther. 17, 81-87.
27. Liston, A., and Rudensky, A.Y. (2007). Thymic development and peripheral homeostasis of regulatory T cells. Curr. Opin. Immunol. 19, 176-185. (Pubitemid 46356966)
28. Manno, C.S., Pierce, G.F., Arruda, V.R., et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342-347. (Pubitemid 43355084)
29. Mingozzi, F., and High, K.A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat. Rev. Genet. 12, 341-355.
30. Mingozzi, F., Maus, M.V., Hui, D.J., et al. (2007). CD8+ T-cell responses to adeno-associated virus capsid in humans. Nat. Med. 13, 419-422. (Pubitemid 46559826)
31. Moss, R.B., Rodman, D., Spencer, L.T., et al. (2004). Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125, 509-521. (Pubitemid 38223630)
32. Moss, R.B., Milla, C., Colombo, J., et al. (2007). Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: A randomized placebo-controlled phase 2B trial. Hum. Gene Ther. 18, 726-732. (Pubitemid 47378069)
33. Mueller, C., and Flotte, T.R. (2008). Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15, 858-863. (Pubitemid 351712619)
34. Nathwani, A.C., Tuddenham, E.G., Rangarajan, S., et al. (2011). Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357-2365.
35. Parsons, D.W., Grubb, B.R., Johnson, L.G., and Boucher, R.C. (1998). Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum. Gene Ther. 9, 2661-2672. (Pubitemid 29027009)
36. Rawlins, E.L., and Hogan, B.L. (2006). Epithelial stem cells of the lung: privileged few or opportunities for many? Development 133, 2455-2465. (Pubitemid 44123396)
37. Sabatino, D.E., Mackenzie, T.C., Peranteau, W., et al. (2007). Persistent expression of hF.IX after tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol. Ther. 15, 1677-1685. (Pubitemid 47289012)
38. Sheridan, C. (2011). Gene therapy finds its niche. Nat. Biotechnol. 29, 121-128.
39. Sinn, P.L., Arias, A.C., Brogden, K.A., and McCray, P.B., Jr. (2008). Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J. Virol. 82, 10684-10692. (Pubitemid 352691165)
40. Sumner-Jones, S.G., Davies, L.A., Varathalingam, A., et al. (2006). Long-term persistence of gene expression from adenoassociated virus serotype 5 in the mouse airways. Gene Ther. 13, 1703-1713. (Pubitemid 44849035)
41. Tran, N.D., Porada, C.D., Almeida-Porada, G., et al. (2001). Induction of stable prenatal tolerance to b-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood 97, 3417-3423.
42. Vandenberghe, L.H., Wilson, J.M., and Gao, G. (2009). Tailoring the AAV vector capsid for gene therapy. Gene Ther. 16, 311-319.
43. Van der Perren, A., Toelen, J., Carlon, M., et al. (2011). Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9. Gene Ther. 18, 517-527.
44. Waddington, S.N., Buckley, S.M., Nivsarkar, M., et al. (2003). In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor. Blood 101, 1359-1366. (Pubitemid 36182507)
45. Wagner, J.A., Messner, A.H., Moran, M.L., et al. (1999). Safety and biological efficacy of an adeno-associated virus vectorcystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 109, 266-274. (Pubitemid 29075570)
46. Wagner, J.A., Nepomuceno, I.B., Messner, A.H., et al. (2002). A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. 13, 1349-1359.
47. Wang, L., Figueredo, J., Calcedo, R., et al. (2007). Crosspresentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets. Hum. Gene Ther. 18, 185-194. (Pubitemid 46626458)
48. Wang, L., Wang, H., Bell, P., et al. (2012). Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector. Hum. Gene Ther. 23, 533-539.
49. Wang, Z., Tapscott, S.J., Chamberlain, J.S., and Storb, R. (2011). Immunity and AAV-mediated gene therapy for muscular dystrophies in large animal models and human trials. Front. Microbiol. 2, 201.
50. Weinstein, D.A., Correia, C.E., Conlon, T., et al. (2010). Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia. Hum. Gene Ther. 21, 903-910.
51. West, L.J. (2002). Defining critical windows in the development of the human immune system. Hum. Exp. Toxicol. 21, 499-505.
52. Zabner, J., Couture, L.A., Gregory, R.J., et al. (1993). Adenovirusmediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216. (Pubitemid 23320285)
53. Zabner, J., Seiler, M.,Walters, R., et al. (2000). Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74, 3852-3858. (Pubitemid 30180327)